No Data
No Data
Express News | Stoke Therapeutics Inc Files for Shelf of up to 10.8 Mln Shares of Common Stock by Selling Stockholders - SEC Filing
Companies Like Stoke Therapeutics (NASDAQ:STOK) Are In A Position To Invest In Growth
Just because a business does not make any money, does not mean that the stock will go down. For example, although software-as-a-service business Salesforce.com lost money for years while it grew rec
Stoke Therapeutics(STOK.US) Officer Sells US$152.19K in Common Stock
$Stoke Therapeutics(STOK.US)$ Officer Ticho Barry sold 10,000 shares of common stock on Jun 3, 2024 at an average price of $15.2185 for a total value of $152.19K.Source: Announcement What is statement
Stoke Therapeutics to Present at Upcoming Investor Conferences in June
BEDFORD, Mass.--(BUSINESS WIRE)--Jun. 3, 2024-- Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein
Insider Sale: CEO Edward M. Kaye of Stoke Therapeutics Inc (STOK) Sells 42,350 Shares
Stoke Therapeutics(STOK.US) Officer Sells US$769.5K in Common Stock
$Stoke Therapeutics(STOK.US)$ Officer Nash Huw M. sold 50,000 shares of common stock on May 20, 2024 at an average price of $15.39 for a total value of $769.5K.Source: Announcement What is statement o
No Data
Jaguar8 : Oh wow
Jaguar8 : Good morning brother!
TrytosaveabitOP Jaguar8: Good morning my man!
TrytosaveabitOP Jaguar8: I was thinking it was going to be like 8/9 dollars! Hehehe
Jaguar8 : Only had 1.5hrs sleep
View more comments...